Related Experiment Video
Updated: Jun 18, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Long-term outcome of infants with severe chronic kidney disease
Djalila Mekahli1, Vanessa Shaw, Sarah E Ledermann
1Renal Office, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London WC1N 3JH, UK.
Insights
Children with severe chronic kidney disease (CKD) experienced impaired growth, but intensive feeding and early kidney transplant improved outcomes. Comorbidities significantly impacted final height in these young CKD patients.
Area of Science:
- Pediatric Nephrology
- Chronic Kidney Disease Research
- Growth and Development Studies
Background:
- Long-term outcomes for infants with severe chronic kidney disease (CKD) are not well-documented.
- Previous reports detailed 101 children with a glomerular filtration rate (GFR) <20 ml/min/1.73 m2 at a median age of 0.3 years.
Purpose of the Study:
- To reanalyze long-term data on mortality, treatment, and growth in children with severe CKD.
- To investigate the impact of comorbidities on growth and final height in this cohort.
Main Methods:
- Retrospective analysis of 101 children with severe CKD (GFR <20 ml/min/1.73 m2).
- Data reanalyzed approximately 9.9 years after initial reporting, covering a total follow-up of up to 22.9 years.
- Evaluation of mortality, treatment modalities (tube feeding, gastrostomy, Nissen fundoplication), and growth parameters (height SD score).
Main Results:
- Overall survival at 22 years was 64%.
- Comorbidities were present in 51% of patients and adversely affected growth (P < 0.01) and final height (P = 0.02).
- Mean height SD score at birth was -0.42, declining to -2.07 at 0.5 years, and improving to -1.68 in adulthood for those without comorbidities.
Conclusions:
- Comorbidity significantly influences growth and final height in infants with severe CKD.
- Intensive nutritional support and early kidney transplantation can lead to normal adult height in patients without comorbidities.
- Overall mortality in this cohort is comparable to that of older children with CKD.
Background And Objectives:
In 2000, we reported the outcome of 101 children with a GFR <20 ml/min per 1.73 m2 at 0.3 yr of age (range 0.0 to 1.5 yr). Long-term data on such young children are scarce.
Design, Setting, Participants, & Measurements:
Mortality, treatment modalities, and growth were reanalyzed 9.9 yr later.
Results:
Of the 101 patients, 28 died and three were lost to follow-up during 13.90 yr (range 0.03 to 22.90 yr). One-, 2-, 5-, 10-, 15-, 20-, and 22-yr survivals were 87, 81, 77, 75, 73, 72, and 64%, respectively. Fifty-one children had comorbidities. Sixty-six percent were tube fed for 1.7 yr (range 0.1 to 6.9 yr), 37% had a gastrostomy, and 13% had a Nissen fundoplication. Mean height SD score (SD) was -0.42 (2.33) at birth (n = 40), -2.07 (1.34) at 0.5 (n = 62), -1.93 (1.38) at 1 (n = 72), -1.14 (1.14) at 5 (n = 67), -1.04 (1.15) at 10 (n = 62), -1.84 (1.32) at 15 (n = 40), and -1.68 (1.52) at age > or =18 yr (n = 32). Comorbidities adversely influenced growth (P < 0.01) and final height (P = 0.02): Mean height SD score (SD) was -1.16 (1.38) in otherwise normal adults.
Conclusions:
Growth and final height in infants with severe chronic kidney disease are influenced by comorbidity. Intensive feeding and early transplantation resulted in a mean adult height within the normal range in patients without comorbidities. Overall mortality is comparable to that of older children.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
